XML 70 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segments and Geographic Data
9 Months Ended
Sep. 30, 2014
Business Segments and Geographic Data [Abstract]  
Business Segments and Geographic Data
Note 14
Business Segments and Geographic Data:

Following the acquisition of LCA-Vision, the Company’s business was aligned into four operating segments based upon the Company’s management structure, products and services offered, markets served and types of customers, as follows: The Consumer segment derives its revenues from the design, development, manufacturing and selling of long-term hair reduction and acne consumer products. The Physician Recurring segment derives its revenues from the XTRAC procedures performed by dermatologists, the sales of skincare products, the sales of surgical disposables and accessories to hospitals and surgery centers and on the repair, maintenance and replacement parts on our various products. The Professional segment generates revenues from the sale of equipment, such as lasers, medical and esthetic light and heat-based products and LED products. The Clinics segment generates revenues from services performed and products sold in our vision centers. Management reviews financial information presented on an operating segment basis for the purposes of making certain operating decisions and assessing financial performance.

Unallocated operating expenses include costs that are not specific to a particular segment but are general to the group; included are expenses incurred for administrative and accounting staff, general liability and other insurance, professional fees and other similar corporate expenses. Unallocated assets include cash and cash equivalents, prepaid expenses and deposits.

The following tables reflect results of operations from our business segments for the periods indicated below:

  
Three Months Ended September 30, 2014 (unaudited)
 
  
Consumer
  
Physician Recurring
  
Professional
  
Clinics
  
Total
 
Revenues
 
$
24,938
  
$
8,823
  
$
1,850
  
$
18,092
  
$
53,703
 
Costs of revenues
  
4,363
   
3,094
   
1,258
   
14,246
   
22,961
 
Gross profit
  
20,575
   
5,729
   
592
   
3,846
   
30,742
 
Gross profit %
  
82.5
%
  
64.9
%
  
32.0
%
  
21.3
%
  
57.2
%
                     
Allocated operating expenses:
                    
Engineering and product development
  
306
   
314
   
201
   
-
   
821
 
Selling and marketing expenses
  
20,001
   
3,843
   
204
   
4,792
   
28,840
 
                     
Unallocated operating expenses
  
-
   
-
   
-
   
-
   
11,678
 
   
20,307
   
4,157
   
405
   
4,792
   
41,339
 
Income (loss) from operations
  
268
   
1,572
   
187
   
(946
)
  
(10,597
)
                     
Interest  and other financing expense, net
  
-
   
-
   
-
   
-
   
(3,824
)
                     
Net income (loss) before taxes
 
$
268
  
$
1,572
  
$
187
  
$
(946
)
 
(14,421
)

  
Three Months Ended September 30, 2013 (unaudited)
 
  
Consumer
  
Physician Recurring
  
Professional
  
Clinics
  
Total
 
Revenues
 
$
36,910
  
$
7,359
  
$
1,624
  
$
-
  
$
45,893
 
Costs of revenues
  
4,730
   
3,272
   
1,064
   
-
   
9,066
 
Gross profit
  
32,180
   
4,087
   
560
   
-
   
36,827
 
Gross profit %
  
87.2
%
  
55.5
%
  
34.5
%
  
N/
A  
80.2
%
                     
Allocated operating expenses:
                    
Engineering and product development
  
279
   
341
   
185
   
-
   
805
 
Selling and marketing expenses
  
26,958
   
3,370
   
645
   
-
   
30,973
 
                     
Unallocated operating expenses
  
-
   
-
   
-
   
-
   
5,972
 
   
27,237
   
3,711
   
830
   
-
   
37,750
 
Income (loss) from operations
  
4,943
   
376
   
(270
)
  
-
   
(923
)
                     
Interest and other financing expense, net
  
-
   
-
   
-
   
-
   
473
 
                     
Net income (loss) before taxes
 
$
4,943
  
$
376
  
(270
)
 
$
-
  
(450
)

  
Nine Months Ended September 30, 2014 (unaudited)
 
  
Consumer
  
Physician Recurring
  
Professional
  
Clinics
  
Total
 
Revenues
 
$
94,261
  
$
24,649
  
$
5,753
  
$
31,235
  
$
155,898
 
Costs of revenues
  
14,596
   
9,349
   
3,884
   
23,129
   
50,958
 
Gross profit
  
79,665
   
15,300
   
1,869
   
8,106
   
104,940
 
Gross profit %
  
84.5
%
  
62.1
%
  
32.5
%
  
26.0
%
  
67.3
%
                     
Allocated operating expenses:
                    
Engineering and product development
  
898
   
881
   
560
   
-
   
2,339
 
Selling and marketing expenses
  
70,382
   
12,122
   
935
   
7,447
   
90,886
 
                     
Unallocated operating expenses
  
-
   
-
   
-
   
-
   
30,717
 
   
71,280
   
13,003
   
1,495
   
7,447
   
123,942
 
Income (loss) from operations
  
8,385
   
2,297
   
374
   
659
   
(19,002
)
                     
Interest and other financing expense, net
  
-
   
-
   
-
   
-
   
(4,145
)
                     
Net income (loss) before taxes
 
$
8,385
  
$
2,297
  
$
374
  
$
659
  
(23,147
)

  
Nine Months Ended September 30, 2013 (unaudited)
 
  
Consumer
  
Physician Recurring
  
Professional
  
Clinics
  
Total
 
Revenues
 
$
134,643
   
20,690
  
$
5,841
  
$
-
  
$
161,174
 
Costs of revenues
  
19,422
   
9,217
   
3,683
   
-
   
32,322
 
Gross profit
  
115,221
   
11,473
   
2,158
   
-
   
128,852
 
Gross profit %
  
85.6
%
  
55.5
%
  
36.9
%
  
N/
A  
79.9
%
                     
Allocated operating expenses:
                    
Engineering and product development
  
775
   
982
   
635
   
-
   
2,392
 
Selling and marketing expenses
  
79,293
   
9,777
   
1,697
   
-
   
90,767
 
                     
Unallocated operating expenses
  
-
   
-
   
-
   
-
   
17,899
 
   
80,068
   
10,759
   
2,332
   
-
   
111,058
 
Income (loss) from operations
  
35,153
   
714
   
(174
)
  
-
   
17,794
 
                     
Interest  and other financing income, net
  
-
   
-
   
-
   
-
   
470
 
                     
Net income before taxes
 
$
35,153
  
$
714
  
(174
)
 
$
-
  
$
18,264
 

For the three and nine months ended September 30, 2014 and 2013 (unaudited), net revenues by geographic area were as follows:

  
Three Months Ended
September 30,
  
Nine Months Ended
September 30,
 
  
2014
  
2013
  
2014
  
2013
 
North America 1
 
$
43,792
  
$
35,239
  
$
125,568
  
$
122,170
 
Asia Pacific 2
  
2,248
   
1,778
   
7,263
   
16,980
 
Europe (including Israel)
  
7,423
   
8,083
   
21,915
   
19,577
 
South America
  
240
   
793
   
1,152
   
2,447
 
  
$
53,703
  
$
45,893
  
$
155,898
  
$
161,174
 
                 
1 United States
 
$
41,338
  
$
30,287
  
$
114,718
  
$
98,832
 
1 Canada
 
$
2,454
  
$
4,952
  
$
10,850
  
$
23,338
 
Japan
 
$
435
  
$
205
  
$
1,423
  
$
11,455
 

As of September 30, 2014 and December 31, 2013, long-lived assets by geographic area were as follows:

  
September 30, 2014
  
December 31, 2013
 
  
(unaudited)
   
North America
 
$
27,399
  
$
9,119
 
Asia Pacific
  
249
   
-
 
Europe (including Israel)
  
1,197
   
1,370
 
South America
  
4
   
-
 
  
$
28,849
  
$
10,489
 

The Company discusses segmental details in its Management Discussion and Analysis found elsewhere in this Quarterly Report on Form 10-Q.